1
|
Argyropoulos CD, Leckler J, Salmanton-García J, Constantinou M, Alexandrou A, Themistocleous S, Noula E, Shiamakkides G, Nearchou A, Stewart FA, Albus K, Koniordou M, Kopsidas I, Spivak O, Hellemans M, Hendrickx G, Davis RJ, Azzini AM, Simon PV, Carcas AJ, Askling HH, Vene S, Prellezo JB, Álvarez-Barco E, Macken AJ, Di Marzo R, Luís C, Olesen OF, Frias Iniesta JA, Barta I, Tóth K, Akova M, Bonten MMJ, Cohen-Kandli M, Cox RJ, Součková L, Husa P, Jancoriene L, Launay O, Lundgren J, Mallon P, Mendonça MA, Marques L, Naucler P, Ochando J, Tacconelli E, van Damme P, Zaoutis T, Hofstraat S, Bruijning-Verhagen P, Zeitlinger M, Cornely OA, Pana ZD. Enhancing public health communication of vaccine trials: The pan-European VACCELERATE Toolkit. JMIR Public Health Surveill 2023; 9:e44491. [PMID: 36878478 PMCID: PMC10131613 DOI: 10.2196/44491] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2022] [Revised: 02/09/2023] [Accepted: 02/28/2023] [Indexed: 03/08/2023] Open
Abstract
BACKGROUND The pan-European VACCELERATE network aims to implement the first transnational harmonised and sustainable vaccine trial Volunteer Registry, serving as single entry-point for volunteers willing to participate in large scale vaccine clinical studies across the European region. The present work exhibits a set of harmonised vaccine trial educational and promotional tools for the general public, designed and disseminated by the pan-European VACCELERATE network. OBJECTIVE The main objectives of the present study are the design and creation of a standard toolkit to increase positive attitudes, and access to trustful information for better access and increased recruitment to vaccine trials for the public community. More specifically, the produced tools are focused on inclusiveness, equity, and they are targeting different population groups, including underserved ones, as potential volunteers for the VACCELERATE Volunteer Registry (elderly, migrants, children and adolescents). The promotion/education material is aligned with the main objectives of the Volunteer Registry, to increase public literacy and awareness regarding vaccine clinical research/trials and trial participation, such as informed consent and legal issues, side effects and frequently asked questions on vaccine trial design. METHODS The tools' development has followed the aims and principles of the VACCELERATE project, focusing on trial inclusiveness and equity and they are adjusted to the local country requirements to improve public health communication. The selection of the produced tools has been based on the cognitive theory, inclusiveness and equity of different aged and under-represented groups, and standardised material from several official trustful sources (e.g. COVAX, ECDC, EUPATI, GAVI and WHO). In addition, team of specialists from different fields (infectious diseases, vaccine research, medicine, education) edited and reviewed the subtitles and scripts for the educational videos, extended brochures, interactive cards and puzzles. Graph designers also selected the colour palette, audio settings and dubbing for the video story-tales and implementation of QR codes. RESULTS This study presents the first set of harmonised promotional and educational materials/tools (i.e. educational cards, educational and promotional videos, extended brochures, flyers, posters, and puzzles) for vaccine clinical research (e.g. COVID-19). The developed tools inform the public about possible benefits and disadvantages of trial participation, but also build the confidence of participants about the safety and efficacy for COVID-19 vaccines and healthcare system. The present material has been translated into several languages and meant to be freely and easily accessible to facilitate dissemination among the participating countries of the VACCELERATE network, as well as among the European and global scientific, industrial, and public community, in general. CONCLUSIONS The produced material could also be useful for filling knowledge gaps of healthcare personnel and providing the appropriate future patient education for vaccine trials, as well as to tackle vaccine hesitancy and parents' concerns for potential participation of children in vaccine trials.
Collapse
Affiliation(s)
| | - Janina Leckler
- University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, DE.,University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, DE
| | - Jon Salmanton-García
- University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, DE.,University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, DE
| | | | | | | | - Evgenia Noula
- School of Medicine, European University Cyprus, 6 Diogenis Str., Nicosia, CY
| | - George Shiamakkides
- School of Medicine, European University Cyprus, 6 Diogenis Str., Nicosia, CY
| | - Andria Nearchou
- School of Medicine, European University Cyprus, 6 Diogenis Str., Nicosia, CY
| | - Fiona A Stewart
- University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, DE.,University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, DE
| | - Kerstin Albus
- University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, DE.,University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, DE
| | - Markela Koniordou
- Collaborative Center for Clinical Epidemiology and Outcomes Research (CLEO), Athens, GR
| | - Ioannis Kopsidas
- Collaborative Center for Clinical Epidemiology and Outcomes Research (CLEO), Athens, GR
| | | | - Margot Hellemans
- Universiteit Antwerpen, Faculty of Medicine and Health Science, VAXINFECTIO, Centre of Evaluation of Vaccination, Antwerp, BE
| | - Greet Hendrickx
- Universiteit Antwerpen, Faculty of Medicine and Health Science, VAXINFECTIO, Centre of Evaluation of Vaccination, Antwerp, BE
| | - Ruth Joanna Davis
- University of Verona, Infectious Diseases, Department of Diagnostic and Public Health, Verona, IT
| | - Anna Maria Azzini
- University of Verona, Infectious Diseases, Department of Diagnostic and Public Health, Verona, IT
| | - Paula Valle Simon
- Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, ES.,Servicio Madrileño de Salud, Madrid, ES
| | - Antonio Javier Carcas
- Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, ES.,Servicio Madrileño de Salud, Madrid, ES
| | - Helena Hervius Askling
- Department of Infectious Diseases, Karolinska University Hospital, Stockholm, SE.,Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, SE
| | - Sirkka Vene
- Department of Infectious Diseases, Karolinska University Hospital, Stockholm, SE.,Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, SE
| | | | - Elena Álvarez-Barco
- Centre for Experimental Pathogen Host Research, University College Dublin School of Medicine, National University of Ireland, Dublin, IE
| | - Alan J Macken
- Centre for Experimental Pathogen Host Research, University College Dublin School of Medicine, National University of Ireland, Dublin, IE
| | | | | | - Ole F Olesen
- European Vaccine Initiative (EVI), Heidelberg, DE
| | - Jesus A Frias Iniesta
- Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, ES.,Servicio Madrileño de Salud, Madrid, ES
| | - Imre Barta
- National Koranyi Institute for Pulmonology, Budapest, HU
| | - Krisztina Tóth
- National Koranyi Institute for Pulmonology, Budapest, HU
| | | | - Marc M J Bonten
- Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, NL.,Department of Medical Microbiology, University Medical Centre Utrecht, Utrecht, NL
| | | | | | - Lenka Součková
- Masaryk University, Brno, Czech Republic, University Hospital Brno, Brno, CZ.,University Hospital Brno, Brno, CZ.,CZECRIN, Brno, CZ
| | - Petr Husa
- Masaryk University, Brno, Czech Republic, University Hospital Brno, Brno, CZ.,University Hospital Brno, Brno, CZ.,CZECRIN, Brno, CZ
| | - Ligita Jancoriene
- Institute of Clinical Medicine, Medical Faculty, Vilnius University, Vilnius, LT.,Vilnius University Hospital Santaros klinikos, Medical Faculty, Vilnius University, Vilnius, LT
| | - Odile Launay
- Institut National de la Santé et de la Recherche Médicale-ANRS Maladies Infectieuses Émergentes, Paris, FR.,Université Paris Cité, Assistance Publique Hopitaux de Paris, Paris, FR
| | - Jens Lundgren
- Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, University of Copenhagen, Copenhagen, DK
| | - Patrick Mallon
- Centre for Experimental Pathogen Host Research, University College Dublin School of Medicine, National University of Ireland, Dublin, IE
| | | | | | - Pontus Naucler
- Department of Infectious Diseases, Karolinska University Hospital, Stockholm, SE.,Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, SE
| | - Jordi Ochando
- Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, ES
| | - Evelina Tacconelli
- University of Verona, Infectious Diseases, Department of Diagnostic and Public Health, Verona, IT
| | - Pierre van Damme
- Universiteit Antwerpen, Faculty of Medicine and Health Science, VAXINFECTIO, Centre of Evaluation of Vaccination, Antwerp, BE
| | - Theoklis Zaoutis
- Collaborative Center for Clinical Epidemiology and Outcomes Research (CLEO), Athens, GR
| | - Sanne Hofstraat
- University Medical Centre Utrecht, Utrecht University, Utrecht, NL
| | | | | | - Oliver A Cornely
- University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, DE.,University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, DE.,University of Cologne, Faculty of Medicine and University Hospital Cologne, Clinical Trials Centre Cologne (ZKS Köln), Cologne, DE.,University of Cologne, Faculty of Medicine and University Hospital Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, DE.,German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, DE
| | - Zoi Dorothea Pana
- School of Medicine, European University Cyprus, 6 Diogenis Str., Nicosia, CY
| |
Collapse
|
2
|
Manuel AR, Gonçalves C, Silva A, Escobar C, Manaças R, Luís C. Reversible Cerebral Vasoconstriction Syndrome in a Previously Healthy Child: A Case Report. Neurol Clin Pract 2022; 12:e116-e120. [DOI: 10.1212/cpj.0000000000200069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2022] [Accepted: 06/21/2022] [Indexed: 11/15/2022]
Abstract
AbstractObjectives:We describe the case of a healthy boy diagnosed with reversible cerebral vasoconstriction syndrome (RCVS) and posterior reversible encephalopathy syndrome (PRES).Methods:He was identified after presenting in the emergency department (ED). A review of the five previous cases of RCVS complicated with PRES reported in the literature was performed.Results:A 9-year-old boy was brought to the ED for intense, throbbing headache and vomiting. Physical and neurological examinations were normal. Brain computed tomography and cerebrospinal fluid examination were unremarkable, and he was discharged after symptomatic relief. Five days later, he returned to the ED for generalized tonic-clonic seizures that ceased with levetiracetam. Magnetic resonance imaging (MRI) with angiography showed PRES. Systolic hypertension refractory to therapy was documented. New-onset fluctuating right-sided paresis and paresthesia appeared, so MRI was repeated, showing diffuse cerebral vasoconstriction suggesting RCVS. Nimodipine was started with complete resolution of symptoms and normalization of blood pressure. Four weeks after discharge, TD and MRI showed total vasospasm resolution. There was no recurrence in 12 months follow-up.Discussion:This case emphasizes the interconnection between RCVS and PRES, highlighting the need to include both as differential diagnoses for severe headache and the essential role of MR angiography in the investigation.
Collapse
|
3
|
Salmanton-García J, Stewart FA, Heringer S, Koniordou M, Álvarez-Barco E, Argyropoulos CD, Themistocleous SC, Valle-Simón P, Spivak O, Součková L, Merakou C, Amélia Mendonça M, Joanna Davis R, Maria Azzini A, Askling HH, Vene S, Van Damme P, Steinbach A, Shiamakkides G, Seidel D, Olesen OF, Noula E, Macken A, Luís C, Leckler J, Launay O, Isitt C, Hellemans M, Frías-Iniesta J, Di Marzo R, Carcas AJ, Boustras G, Borobia AM, Barta I, Albus K, Akova M, Ochando J, Cohen-Kandli M, Jane Cox R, Husa P, Jancoriene L, Mallon P, Marques L, Mellinghoff SC, Nauclér P, Tacconelli E, Tóth K, Zaoutis TE, Zeitlinger M, Cornely OA, Pana ZD. VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment. Vaccine 2022; 40:4090-4097. [PMID: 35659449 PMCID: PMC9159788 DOI: 10.1016/j.vaccine.2022.05.022] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2022] [Revised: 05/03/2022] [Accepted: 05/06/2022] [Indexed: 11/19/2022]
Abstract
INTRODUCTION The coronavirus disease 2019 (COVID-19) pandemic has evidenced the key role of vaccine design, obtention, production and administration to successfully fight against infectious diseases and to provide efficient remedies for the citizens. Although clinical trials were rapidly established during this pandemic, identifying suitable study subjects can be challenging. For this reason, the University Hospital Cologne established a volunteer registry for participation in clinical trials first in Germany, which has now been incorporated into the European VACCELERATE clinical trials network and grew to a European Volunteer Registry. As such, VACCELERATE's Volunteer Registry aims to become a common entry point for potential volunteers in future clinical trials in Europe. METHODS Interested volunteers who would like to register for clinical trials in the VACCELERATE Volunteer Registry can access the registration questionnaire via http://www.vaccelerate.eu/volunteer-registry. Potential volunteers are requested to provide their current country and area of residence, contact information, including first and last name and e-mail address, age, gender, comorbidities, previous SARS-CoV-2 infection and vaccination status, and maximum distance willing to travel to a clinical trial site. The registry is open to both adults and children, complying with national legal consent requirements. RESULTS As of May 2022, the questionnaire is available in 12 countries and 14 languages. Up to date, more than 36,000 volunteers have registered, mainly from Germany. Within the first year since its establishment, the VACCELERATE Volunteer Registry has matched more than 15,000 volunteers to clinical trials. The VACCELERATE Volunteer Registry will be launched in further European countries in the coming months. CONCLUSIONS The VACCELERATE Volunteer Registry is an active single-entry point for European residents interested in COVID-19 clinical trials participation in 12 countries (i.e., Austria, Cyprus, Germany, Greece, Ireland, Lithuania, Norway, Portugal, Spain, Sweden and Turkey). To date, more than 15,000 registered individuals have been connected to clinical trials in Germany alone. The registry is currently in the implementation phase in 5 additional countries (i.e., Belgium, Czech Republic, Hungary, Israel and the Netherlands).
Collapse
Affiliation(s)
- Jon Salmanton-García
- University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany
| | - Fiona A Stewart
- University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany
| | - Sarah Heringer
- University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany
| | - Markela Koniordou
- Collaborative Center for Clinical Epidemiology and Outcomes Research (CLEO), Athens, Greece
| | - Elena Álvarez-Barco
- Centre for Experimental Pathogen Host Research, University College Dublin School of Medicine, National University of Ireland, Dublin, Ireland
| | | | | | - Paula Valle-Simón
- Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain; Servicio Madrileño de Salud, Madrid, Spain
| | - Orly Spivak
- Ministry of Health of Israel, Jerusalem, Israel
| | - Lenka Součková
- Masaryk University, Brno, Czech Republic, University Hospital Brno, Brno, Czech Republic, CZECRIN, Brno, Czech Republic
| | - Christina Merakou
- Collaborative Center for Clinical Epidemiology and Outcomes Research (CLEO), Athens, Greece
| | | | - Ruth Joanna Davis
- University of Verona, Infectious Diseases, Department of Diagnostic and Public Health, Verona, Italy
| | - Anna Maria Azzini
- University of Verona, Infectious Diseases, Department of Diagnostic and Public Health, Verona, Italy
| | - Helena H Askling
- Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden, Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden
| | - Sirkka Vene
- Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden, Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden
| | - Pierre Van Damme
- Universiteit Antwerpen, Faculty of Medicine and Health Science, VAXINFECTIO, Centre of Evaluation of Vaccination, Antwerp, Belgium
| | - Angela Steinbach
- University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany
| | | | - Danila Seidel
- University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany
| | - Ole F Olesen
- European Vaccine Initiative (EVI), Heidelberg, Germany
| | | | - Alan Macken
- Centre for Experimental Pathogen Host Research, University College Dublin School of Medicine, National University of Ireland, Dublin, Ireland
| | - Catarina Luís
- European Vaccine Initiative (EVI), Heidelberg, Germany
| | - Janina Leckler
- University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany
| | - Odile Launay
- Institut National de la Santé et de la Recherche Médicale-ANRS Maladies Infectieuses Émergentes, Paris, France; Université Paris Cité, Assistance Publique Hopitaux de Paris, Paris, France
| | - Catherine Isitt
- Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden, Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden
| | - Margot Hellemans
- Universiteit Antwerpen, Faculty of Medicine and Health Science, VAXINFECTIO, Centre of Evaluation of Vaccination, Antwerp, Belgium
| | - Jesús Frías-Iniesta
- Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain; Servicio Madrileño de Salud, Madrid, Spain
| | | | - Antonio J Carcas
- Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain; Servicio Madrileño de Salud, Madrid, Spain
| | | | - Alberto M Borobia
- Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain; Servicio Madrileño de Salud, Madrid, Spain
| | - Imre Barta
- National Koranyi Institute for Pulmonology, Budapest, Hungary
| | - Kerstin Albus
- University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany
| | | | - Jordi Ochando
- Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain
| | | | - Rebecca Jane Cox
- Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway
| | - Petr Husa
- Masaryk University, Brno, Czech Republic, University Hospital Brno, Brno, Czech Republic, CZECRIN, Brno, Czech Republic
| | - Ligita Jancoriene
- Institute of Clinical Medicine, Medical Faculty, Vilnius University|Institute of Clinical Medicine, Medical Faculty, Vilnius University; Vilnius University Hospital Santaros klinikos, Vilnius University, Medical Faculty, Vilnius, Lithuania
| | - Patrick Mallon
- Centre for Experimental Pathogen Host Research, University College Dublin School of Medicine, National University of Ireland, Dublin, Ireland
| | - Laura Marques
- Centro Hospitalar Universitário do Porto, Porto, Portugal
| | - Sibylle C Mellinghoff
- University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany
| | - Pontus Nauclér
- Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden, Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden
| | - Evelina Tacconelli
- University of Verona, Infectious Diseases, Department of Diagnostic and Public Health, Verona, Italy
| | - Krisztina Tóth
- National Koranyi Institute for Pulmonology, Budapest, Hungary
| | - Theoklis E Zaoutis
- Collaborative Center for Clinical Epidemiology and Outcomes Research (CLEO), Athens, Greece
| | | | - Oliver A Cornely
- University of Cologne, Faculty of Medicine and University Hospital Cologne, Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Cologne, Germany; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany; University of Cologne, Faculty of Medicine and University Hospital Cologne, Clinical Trials Centre Cologne (ZKS Köln), Cologne, Germany
| | | |
Collapse
|
4
|
Forno A, Cunha B, Luís C, Castro A, Moniz M, Escobar C, Lamy S, Pereira A, Martins A, Conceição C. Wernicke Encephalopathy in Children. Neurol Clin Pract 2021; 11:e777-e780. [PMID: 34840908 DOI: 10.1212/cpj.0000000000000973] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2020] [Accepted: 07/31/2020] [Indexed: 11/15/2022]
Affiliation(s)
- Andreia Forno
- Department of Pediatrics (AF), Hospital Central do Funchal, Madeira; Department of Neuroradiology (BC, CC), Centro Hospitalar Lisboa Central, Lisbon; Neuropediatrics (CL), and Pediatric Intensive Care Unit (AC, MM, CE), Department of Pediatrics, Hospital Prof. Dr. Fernando Fonseca, Lisbon; Pediatric Intensive Care Unit (SL), and Department of Neuropediatrics (AP, AM), Hospital de Dona Estefânia, Centro Hospitalar Lisboa Central, Lisbon, Portugal
| | - Bruno Cunha
- Department of Pediatrics (AF), Hospital Central do Funchal, Madeira; Department of Neuroradiology (BC, CC), Centro Hospitalar Lisboa Central, Lisbon; Neuropediatrics (CL), and Pediatric Intensive Care Unit (AC, MM, CE), Department of Pediatrics, Hospital Prof. Dr. Fernando Fonseca, Lisbon; Pediatric Intensive Care Unit (SL), and Department of Neuropediatrics (AP, AM), Hospital de Dona Estefânia, Centro Hospitalar Lisboa Central, Lisbon, Portugal
| | - Catarina Luís
- Department of Pediatrics (AF), Hospital Central do Funchal, Madeira; Department of Neuroradiology (BC, CC), Centro Hospitalar Lisboa Central, Lisbon; Neuropediatrics (CL), and Pediatric Intensive Care Unit (AC, MM, CE), Department of Pediatrics, Hospital Prof. Dr. Fernando Fonseca, Lisbon; Pediatric Intensive Care Unit (SL), and Department of Neuropediatrics (AP, AM), Hospital de Dona Estefânia, Centro Hospitalar Lisboa Central, Lisbon, Portugal
| | - Ana Castro
- Department of Pediatrics (AF), Hospital Central do Funchal, Madeira; Department of Neuroradiology (BC, CC), Centro Hospitalar Lisboa Central, Lisbon; Neuropediatrics (CL), and Pediatric Intensive Care Unit (AC, MM, CE), Department of Pediatrics, Hospital Prof. Dr. Fernando Fonseca, Lisbon; Pediatric Intensive Care Unit (SL), and Department of Neuropediatrics (AP, AM), Hospital de Dona Estefânia, Centro Hospitalar Lisboa Central, Lisbon, Portugal
| | - Marta Moniz
- Department of Pediatrics (AF), Hospital Central do Funchal, Madeira; Department of Neuroradiology (BC, CC), Centro Hospitalar Lisboa Central, Lisbon; Neuropediatrics (CL), and Pediatric Intensive Care Unit (AC, MM, CE), Department of Pediatrics, Hospital Prof. Dr. Fernando Fonseca, Lisbon; Pediatric Intensive Care Unit (SL), and Department of Neuropediatrics (AP, AM), Hospital de Dona Estefânia, Centro Hospitalar Lisboa Central, Lisbon, Portugal
| | - Carlos Escobar
- Department of Pediatrics (AF), Hospital Central do Funchal, Madeira; Department of Neuroradiology (BC, CC), Centro Hospitalar Lisboa Central, Lisbon; Neuropediatrics (CL), and Pediatric Intensive Care Unit (AC, MM, CE), Department of Pediatrics, Hospital Prof. Dr. Fernando Fonseca, Lisbon; Pediatric Intensive Care Unit (SL), and Department of Neuropediatrics (AP, AM), Hospital de Dona Estefânia, Centro Hospitalar Lisboa Central, Lisbon, Portugal
| | - Sérgio Lamy
- Department of Pediatrics (AF), Hospital Central do Funchal, Madeira; Department of Neuroradiology (BC, CC), Centro Hospitalar Lisboa Central, Lisbon; Neuropediatrics (CL), and Pediatric Intensive Care Unit (AC, MM, CE), Department of Pediatrics, Hospital Prof. Dr. Fernando Fonseca, Lisbon; Pediatric Intensive Care Unit (SL), and Department of Neuropediatrics (AP, AM), Hospital de Dona Estefânia, Centro Hospitalar Lisboa Central, Lisbon, Portugal
| | - Andreia Pereira
- Department of Pediatrics (AF), Hospital Central do Funchal, Madeira; Department of Neuroradiology (BC, CC), Centro Hospitalar Lisboa Central, Lisbon; Neuropediatrics (CL), and Pediatric Intensive Care Unit (AC, MM, CE), Department of Pediatrics, Hospital Prof. Dr. Fernando Fonseca, Lisbon; Pediatric Intensive Care Unit (SL), and Department of Neuropediatrics (AP, AM), Hospital de Dona Estefânia, Centro Hospitalar Lisboa Central, Lisbon, Portugal
| | - Ana Martins
- Department of Pediatrics (AF), Hospital Central do Funchal, Madeira; Department of Neuroradiology (BC, CC), Centro Hospitalar Lisboa Central, Lisbon; Neuropediatrics (CL), and Pediatric Intensive Care Unit (AC, MM, CE), Department of Pediatrics, Hospital Prof. Dr. Fernando Fonseca, Lisbon; Pediatric Intensive Care Unit (SL), and Department of Neuropediatrics (AP, AM), Hospital de Dona Estefânia, Centro Hospitalar Lisboa Central, Lisbon, Portugal
| | - Carla Conceição
- Department of Pediatrics (AF), Hospital Central do Funchal, Madeira; Department of Neuroradiology (BC, CC), Centro Hospitalar Lisboa Central, Lisbon; Neuropediatrics (CL), and Pediatric Intensive Care Unit (AC, MM, CE), Department of Pediatrics, Hospital Prof. Dr. Fernando Fonseca, Lisbon; Pediatric Intensive Care Unit (SL), and Department of Neuropediatrics (AP, AM), Hospital de Dona Estefânia, Centro Hospitalar Lisboa Central, Lisbon, Portugal
| |
Collapse
|
5
|
Luís C, Algarra M, Câmara JS, Perestrelo R. Comprehensive Insight from Phthalates Occurrence: From Health Outcomes to Emerging Analytical Approaches. Toxics 2021; 9:toxics9070157. [PMID: 34357900 PMCID: PMC8309855 DOI: 10.3390/toxics9070157] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/18/2021] [Revised: 06/27/2021] [Accepted: 06/28/2021] [Indexed: 11/16/2022]
Abstract
Phthalates are a group of chemicals used in a multitude of important industrial products (e.g., medical devices, children's toys, and food packages), mainly as plasticizers to improve mechanical properties such as flexibility, transparency, durability, and longevity of polyvinyl chloride (PVC). The wide occurrence of phthalates in many consumer products, including foods (e.g., bottled water, soft drinks, wine, milk, and meat) brings that most people are exposed to phthalates every day, which raises some concerns. Adverse health outcomes from phthalates exposure have been associated with endocrine disruption, deformities in the human reproductive system, increased risk of preterm birth, carcinogen exposure, among others. Apprehension related to the health risks and ubiquitous incidence of phthalates in foods inspires the development of reliable analytical approaches that allow their detection and quantification at trace levels. The purpose of the current review is to provide information related to the presence of phthalates in the food chain, highlighting the health risks associated with their exposure. Moreover, an overview of emerging extraction procedures and high-resolution analytical approaches for a comprehensive quantification of phthalates is presented.
Collapse
Affiliation(s)
- Catarina Luís
- CQM-Centro de Química da Madeira, Campus da Penteada, Universidade da Madeira, 9020-105 Funchal, Portugal; (C.L.); (J.S.C.)
- Faculdade de Ciências da Vida, Unidade de Ciências Médicas, Universidade da Madeira, Campus Universitário da Penteada, 9020-105 Funchal, Portugal
| | - Manuel Algarra
- Department of Inorganic Chemistry, Faculty of Science, Campus de Teatinos s/n, University of Málaga, 29071 Malaga, Spain;
| | - José S. Câmara
- CQM-Centro de Química da Madeira, Campus da Penteada, Universidade da Madeira, 9020-105 Funchal, Portugal; (C.L.); (J.S.C.)
- Departamento de Química, Faculdade de Ciências e Engenharia, Campus da Penteada, Universidade da Madeira, 9020-105 Funchal, Portugal
| | - Rosa Perestrelo
- CQM-Centro de Química da Madeira, Campus da Penteada, Universidade da Madeira, 9020-105 Funchal, Portugal; (C.L.); (J.S.C.)
- Correspondence: ; Tel.: +351-291-705-224
| |
Collapse
|
6
|
Luís C, Canavarro MC, Fonseca A. Men's Intentions to Recommend Professional Help-Seeking to Their Partners in the Postpartum Period: the Direct and Indirect Effects of Gender-Role Conflict. Int J Environ Res Public Health 2019; 16:ijerph16204002. [PMID: 31635045 PMCID: PMC6843949 DOI: 10.3390/ijerph16204002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/30/2019] [Revised: 10/17/2019] [Accepted: 10/18/2019] [Indexed: 01/20/2023]
Abstract
Women's partners may act as facilitators of professional help-seeking for mental health problems in the postpartum period. This study aimed to examine the sociodemographic and clinical correlates of men's intentions to recommend professional help-seeking to their partners if they display postpartum mood and anxiety disorders and to explore the relationship between gender-role conflict and the intention to recommend help-seeking. A cross-sectional study included 214 adult men in a heterosexual relationship with a partner within the reproductive age. Men presented a high intention to recommend professional help to their partners. All dimensions of gender-role conflict were directly associated with the intention to recommend professional help-seeking (p < 0.05). High levels of gender-role conflict (dimensions success, power and competition, and restricted emotionality) were found to lead to increased levels of stigma and lower levels of intention to seek professional help, which, in turn, translated into lower intention to recommend help-seeking. These results emphasize the importance of developing universal awareness-raising and education campaigns directed at men aiming to reduce levels of gender-role conflict and stigma, and normalize the use of mental health services, to increase men's intentions to recommend professional help-seeking to their partners.
Collapse
Affiliation(s)
- Catarina Luís
- Faculty of Psychology and Educational Sciences, University of Coimbra; Coimbra, 3000-115 Coimbra, Portugal.
| | - Maria Cristina Canavarro
- Center for Research in Neuropsychology and Cognitive-Behavioral Intervention, Faculty of Psychology and Educational Sciences, University of Coimbra, Coimbra, 3000-115 Coimbra, Portugal.
| | - Ana Fonseca
- Center for Research in Neuropsychology and Cognitive-Behavioral Intervention, Faculty of Psychology and Educational Sciences, University of Coimbra, Coimbra, 3000-115 Coimbra, Portugal.
| |
Collapse
|
7
|
Coelho J, dos Santos TP, Ezequiel M, Luís C, Levy Gomes A. Síndrome de hemiconvulsión-hemiplejía-epilepsia: caso clínico y uso de dextrometorfano. Rev Neurol 2019; 69:470-471. [DOI: 10.33588/rn.6911.2019307] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
8
|
Abstract
Intracranial hypertension is a rare entity in prepubertal children, and its differential diagnosis includes a number of systemic diseases, drugs, vitamin deficiencies and excesses, and hereditary conditions. Infectious aetiology is rare. The case of a 9-year-old boy with intracranial hypertension secondary to acute neuroborreliosis is described. He presented with daily pulsatile frontotemporal headache, pallor, photophobia and phonophobia. His neurological examination revealed papilledema with no nuchal rigidity. The lumbar puncture showed increased pressure (50 cm H2O) and lymphocytic pleocytosis. Serum and cerebrospinal fluid (CSF) Borrelia burgdorferi antibodies were positive. This kind of infection is rare in Portugal but a trip to an endemic area was identified. A careful history, considering the exposure to rural areas together with the intracranial hypertension and inflammatory CSF, are important clues to the diagnosis, allowing the institution to select appropriate treatment.
Collapse
Affiliation(s)
- Marta Ezequiel
- Department of Pediatria, Hospital Professor Doutor Fernando Fonseca, EPE, Amadora, Portugal
| | - Ana Teresa Teixeira
- Department of Pediatria, Hospital Professor Doutor Fernando Fonseca, EPE, Amadora, Portugal
| | - Maria João Brito
- Department of Pediatria, Hospital Professor Doutor Fernando Fonseca, EPE, Amadora, Portugal
| | - Catarina Luís
- Department of Pediatria, Hospital Professor Doutor Fernando Fonseca, EPE, Amadora, Portugal
| |
Collapse
|
9
|
Garcia C, Salgueiro AB, Luís C, Correia P, Brito MJ. Acute mastoiditis in children: Middle ear cultures may help in reducing use of broad spectrum antibiotics. Int J Pediatr Otorhinolaryngol 2017; 92:32-37. [PMID: 28012530 DOI: 10.1016/j.ijporl.2016.11.002] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/03/2016] [Revised: 11/06/2016] [Accepted: 11/07/2016] [Indexed: 11/27/2022]
Abstract
BACKGROUND Acute mastoiditis (AM) is a suppurative infection of the mastoid air cells, representing the most frequent complication of acute otitis media. AM remains an important entity in children due to its potential complications and sequelae. We aim to describe the cases of AM admitted at our department, identify risk factors potentially associated with complications and analyse the changes in clinical approach of AM over time. METHODS Case review of clinical files of children admitted with acute mastoiditis from June 1996 to May 2013 at a Lisbon metropolitan area hospital. Data was divided into two groups (prior and after May 2005) in order to evaluate changes in AM approach over the years. RESULTS 135 AM episodes were included. The median age was 3.8 years and 42% children were less than 24 months of age. Symptoms at presentation included fever (69%), ear pain (56%) and otorrhea (40%). Complications occurred in 22% patients and were more common in children under 24 months (33% vs 15%, p ≤ 0.01). Leukocyte count was significantly higher in children with complications (16.7 vs 14.5 × 109/μL, p ≤ 0.05) as was C-Reactive Protein value (13 vs 6.3 mg/dL, p ≤ 0.001). There was a significant association between the development of complications and C-Reactive Protein value at admission (OR 1.892; IC95%: 1.018-2.493, p ≤ 0.01). The optimal cut-off value was 7.21 mg/dL. Over time there was a significant increase in middle ear cultures obtained by tympanocentesis during surgery (2% vs 16%, p ≤ 0,01) and also a decrease in the use of broad spectrum antibiotherapy as initial treatment (52% vs 25%,p ≤ 0,001). CONCLUSIONS Children under 24 months, with high leukocyte count or with high C-Reactive Protein value should be monitored closely since complications tend to be more frequent. A CRP value of 7.21 mg/dL at admission seems to be a good cut-off to monitor children for potential complications. Throughout the period analysed more cultures were performed allowing identification of the pathogens and implementation of appropriate antibiotic therapy.
Collapse
Affiliation(s)
- Catarina Garcia
- Department of Pediatrics, Hospital Prof. Doutor Fernando Fonseca, EPE, Estrada IC-19, 2720-276, Amadora, Portugal.
| | - Ana Bárbara Salgueiro
- Department of Pediatrics, Hospital Prof. Doutor Fernando Fonseca, EPE, Estrada IC-19, 2720-276, Amadora, Portugal.
| | - Catarina Luís
- Department of Pediatrics, Hospital Prof. Doutor Fernando Fonseca, EPE, Estrada IC-19, 2720-276, Amadora, Portugal.
| | - Paula Correia
- Department of Pediatrics, Hospital Prof. Doutor Fernando Fonseca, EPE, Estrada IC-19, 2720-276, Amadora, Portugal.
| | - Maria João Brito
- Department of Pediatrics, Hospital Prof. Doutor Fernando Fonseca, EPE, Estrada IC-19, 2720-276, Amadora, Portugal.
| |
Collapse
|
10
|
Luís C, Cannella N, Spanagel R, Köhr G. Persistent strengthening of the prefrontal cortex - nucleus accumbens pathway during incubation of cocaine-seeking behavior. Neurobiol Learn Mem 2016; 138:281-290. [PMID: 27720809 DOI: 10.1016/j.nlm.2016.10.003] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2016] [Revised: 09/09/2016] [Accepted: 10/04/2016] [Indexed: 12/22/2022]
Abstract
High rates of relapse after prolonged abstinence are often triggered by exposure to drug-associated cues that induce drug craving. Incubation of drug craving is a phenomenon that consists of time-dependent increases in cue-induced drug craving during withdrawal. Plasticity mechanisms in the nucleus accumbens (NAc) underlie drug-seeking responses and involve changes in excitatory synaptic transmission's efficacy. In particular, the prefrontal cortex (PFC) glutamatergic input to the NAc core has been well characterized regarding cocaine-evoked plasticity following non-contingent versus contingent exposure to cocaine or alternatively after protracted abstinence. Still, the synaptic strength during the course of withdrawal compared to drug-naïve condition is unknown, since electrophysiological characterizations are mainly performed in brain slices or focus on distinct time points during cocaine-evoked plasticity in vivo. Here we used an incubation paradigm, in which rats had extended accessed to cocaine self-administration, and underwent cue-induced reinstatement at withdrawal day 1 and 30. Longitudinal in vivo field potential recordings in awake rats showed that chronic contingent exposure to cocaine strengthened the prelimbic PFC to NAc core pathway when compared to pre-cocaine condition. This strengthening was associated with decreased paired-pulse ratios (PPR), indicative of presynaptic enhancement of glutamate release, which persisted throughout withdrawal. Moreover, both field potential increase and PPR reduction after chronic cocaine exposure correlated with the number of cocaine infusions received during training. The present results together with previous findings of withdrawal-dependent postsynaptic enhancement of the PFC-NAc core pathway, suggest an additional presynaptic strengthening that is initiated during self-administration and maintained throughout abstinence in drug-seeking rats. These cocaine-driven neuroadaptations may provide a neural substrate for maladaptive processing of cues that can ultimately trigger craving and relapse.
Collapse
Affiliation(s)
- Catarina Luís
- Physiology of Neural Networks, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Psychopharmacology, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany
| | - Nazzareno Cannella
- Institute of Psychopharmacology, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany
| | - Rainer Spanagel
- Institute of Psychopharmacology, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany
| | - Georg Köhr
- Physiology of Neural Networks, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Psychopharmacology, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany.
| |
Collapse
|
11
|
Palmeira-de-Oliveira R, Luís C, Gaspar C, Bogas E, Morgado M, Guardado M, Castelo Branco M, Fonseca MO, Palmeira-de-Oliveira A. Microbiological quality control of non-sterile compounded medicines prepared in a Portuguese hospital centre. Eur J Hosp Pharm 2016; 23:228-232. [PMID: 31156854 DOI: 10.1136/ejhpharm-2015-000769] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2015] [Revised: 11/23/2015] [Accepted: 12/08/2015] [Indexed: 11/04/2022] Open
Abstract
Objectives This work aimed to evaluate the quality of non-sterile formulations compounded at Centro Hospitalar Cova da Beira (Covilhã, Portugal) immediately after preparation and up to the defined 'beyond-use date'. Methods Microbiological quality control tests were performed in accordance with monograph 5.1.4 of the European Pharmacopoeia 8.0. Samples of compounded products were collected from January to December 2014 after preparation and were analysed immediately and reanalysed after storage under the established conditions, for each preparation. Results In the test period, 392 preparations were analysed, corresponding to 24 different formulations (8 intermediate preparations, 11 oral solutions/suspensions and 5 topical preparations). All preparations were in accordance with the pharmacopoeia specifications immediately after preparation. However, for the formulations 'prednisolone oral solution (5 mg/mL)' and 'nitroglycerine and cinchocaine ointment (0.25%/0.5%)', the microbial counts of some batches exceeded the defined limits after storage up to the beyond-use date. Conclusions These results show that the compounding practices implemented at this pharmacy department are able to ensure the microbiological quality of compounded products. This microbiological quality control methodology also allowed identification of the need to replace formulations shown not to be stable throughout the storage period. On the basis of these results, a monthly routine of microbiological control of a random sample of compounded medicines was established in order to ensure their quality and safety for use.
Collapse
Affiliation(s)
- R Palmeira-de-Oliveira
- Centro Hospitalar Cova da Beira, Covilhã, Portugal.,CJCS-UBI: Health Sciences Research Center, Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal.,Labfit-HPRD-Health Products Research and Development, Covilhã, Portugal
| | - C Luís
- CJCS-UBI: Health Sciences Research Center, Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal
| | - C Gaspar
- CJCS-UBI: Health Sciences Research Center, Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal.,Labfit-HPRD-Health Products Research and Development, Covilhã, Portugal
| | - E Bogas
- Centro Hospitalar Cova da Beira, Covilhã, Portugal
| | - M Morgado
- Centro Hospitalar Cova da Beira, Covilhã, Portugal.,CJCS-UBI: Health Sciences Research Center, Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal
| | - M Guardado
- Centro Hospitalar Cova da Beira, Covilhã, Portugal
| | - M Castelo Branco
- Centro Hospitalar Cova da Beira, Covilhã, Portugal.,CJCS-UBI: Health Sciences Research Center, Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal
| | - M O Fonseca
- Centro Hospitalar Cova da Beira, Covilhã, Portugal
| | - A Palmeira-de-Oliveira
- Centro Hospitalar Cova da Beira, Covilhã, Portugal.,CJCS-UBI: Health Sciences Research Center, Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal.,Labfit-HPRD-Health Products Research and Development, Covilhã, Portugal
| |
Collapse
|
12
|
Mourão J, Neto J, Luís C, Moreno C, Barbosa J, Carvalho J, Tavares J. Dental injury after conventional direct laryngoscopy: a prospective observational study. Anaesthesia 2013; 68:1059-65. [DOI: 10.1111/anae.12342] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/21/2013] [Indexed: 11/30/2022]
Affiliation(s)
| | - J. Neto
- Institute of Biomedical Sciences Abel Salazar; University of Oporto; Oporto; Portugal
| | - C. Luís
- Department of Anaesthesia; Centro Hospitalar São João; EPE; Oporto; Portugal
| | - C. Moreno
- Department of Anaesthesia; Centro Hospitalar São João; EPE; Oporto; Portugal
| | - J. Barbosa
- Center for Medical Education; University of Oporto; Oporto; Portugal
| | - J. Carvalho
- Faculty of Dental Medicine; University of Oporto; Oporto; Portugal
| | - J. Tavares
- Department of Surgery; Faculty of Medicine; University of Oporto; Oporto; Portugal
| |
Collapse
|
13
|
Anacleta V, Santos C, Luís C, Nunes P, Brito MJ. [Immigrant children in a pediatric department: what social problems?]. ACTA MEDICA PORT 2009; 22:743-748. [PMID: 20350456] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2008] [Accepted: 04/24/2009] [Indexed: 05/29/2023]
Abstract
BACKGROUND Hospital Fernando Fonseca is located in a suburban area that houses a great number of immigrants from developing countries. AIMS To characterize and compare the immigrant and portuguese pediatric populations which have been admitted and referred to Social Service department. MATERIAL AND METHODS Prospective study, from November 2004 to March 2005; demographic and socioeconomic data, diagnosis and social problems were analysed. RESULTS A total of 35 children were observed, 22 (62.8%) immigrants, 42.9% of them less than 12-months old, with a predominance of female (54.5%), African origin (81.8%) and poor social-economical status (72.3%). The majority of parents (72.7%) came from a Portuguese Speaking African Country and 58.3% were illegal in our country. Most had a family doctor assigned (81.3%). Nineteen (87.5%) were admitted for organic disease and the social problem was detected later: poverty (9), negligence (7), physical aggression (3), abandon (2), psychological abuse (1), sexual abuse (1). Children were referred to Child Protection Committee (5) and Court (1); 6 children received economical support and 5 needed social support. When compared to the Portuguese population, social problems are more frequent in immigrant children (20% vs.7.5%; p =0,001), especially in African origin (81.8% vs.15.4%; p=0,00); low economic status (7.3% vs.55.6%; p =0.,423 ), poverty (37.5% vs. 26.6%; p=0.313) and physical aggression (13% vs. 8.3%; p =0.313) were more frequent in the immigrant and negligence being the most frequent social problem in the Portuguese population (33.3% vs. 29%; p =0.313). DISCUSSION The growing number of immigrants and their social deficiencies raises important questions related to health care and social support for these families, to facilitate their social integration.
Collapse
Affiliation(s)
- Vanda Anacleta
- Departamento de Pediatria. Hospital Fernando Fonseca. Amadora
| | | | | | | | | |
Collapse
|
14
|
Abstract
Major histocompatibility complex (MHC) typing based on microsatellites can be a valuable approach to understanding the selective processes occurring at linked or physically close MHC genes and can provide important information on variability and relationships of populations. Using microsatellites within or in close proximity with bovine lymphocyte antigen (BoLA) genes, we investigated the polymorphisms in the bovine MHC, known as the BoLA, in eight Portuguese cattle breeds. Additional data from non-BoLA microsatellite loci were also used to compare the variability between these regions. Diversity was higher in BoLA than in non-BoLA microsatellites, as could be observed by the number of alleles, allelic richness and observed heterozygosity. Brava de Lide, a breed selected for aggressiveness and nobility, presented the lowest values of observed heterozygosity and allelic richness in both markers. Results from neutrality tests showed few statistically significant differences between the observed Hardy-Weinberg homozygosity (F) and the expected homozygosity (F(E)), indicating the apparent neutrality of the BoLA microsatellites within the analysed breeds. Nevertheless, we detected a trend of lower values of observed homozygosity compared with the expected one. We also detected some differences in the levels of allelic variability among the four BoLA microsatellites. Our data showed a higher number of alleles at the BoLA-DRB3 locus than at the BoLA-DRBP1 locus. These differences could be related to their physical position in the chromosome and may reflect functional requirements for diversity.
Collapse
Affiliation(s)
- C Bastos-Silveira
- Centro de Biologia Ambiental, Universidade de Lisboa, Museu Nacional de História Natural, 1269-102 Lisboa, Portugal.
| | | | | | | | | |
Collapse
|
15
|
Luís C, Juras R, Oom MM, Cothran EG. Genetic diversity and relationships of Portuguese and other horse breeds based on protein and microsatellite loci variation. Anim Genet 2007; 38:20-7. [PMID: 17257184 DOI: 10.1111/j.1365-2052.2006.01545.x] [Citation(s) in RCA: 63] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
There are three native Portuguese horse breeds: Lusitano, Sorraia and Garrano. This study compares diversity patterns of 17 protein and 12 microsatellite markers in these three as well as 30 other breeds to infer relationships among the breeds and to compare levels of polymorphism of these breeds for use in conservation efforts. The Garrano and the Lusitano showed a high level of genetic diversity, similar to that observed for most of the other analysed breeds, while the Sorraia and Friesian breeds showed low levels of variation for both genetic marker types. The combined protein and microsatellite data produced a tree that fit historical records well and with greater confidence levels than those for either data set alone. The combined genetic diversity and relationship information provides important baseline data for future breed conservation efforts, especially for a critically endangered breed such as the Sorraia.
Collapse
Affiliation(s)
- C Luís
- Universidade de Lisboa, Faculdade de Ciências, Departamento de Biologia Animal, Centro de Biologia Ambiental, Edifício C2-Piso 3, Campo Grande, 1749-016 Lisboa, Portugal.
| | | | | | | |
Collapse
|
16
|
Abstract
A common female founder individual of the Portuguese horse breeds Sorraia and Lusitano was found while conducting research on the variation of the Lusitano mitochondrial DNA lineages in relation to studbook information. We obtained 416-bp control region sequences from 16 descendents of a female Sorraia founder (Pomba) still represented in the living population of the Lusitano, according to the most recent edition of this breed's studbook. The same haplotype was found for all analysed samples and belongs to the haplogroup described by several authors as having predominantly Iberian, South American and North African haplotypes bringing new insights on the relationship between the Sorraia and the other Iberian breeds. This work illustrates how weak the boundary of breed establishment can be, especially at the same geographical region. Using the same founders in different breeds is surely one of the explanations to frequently shared haplotypes among recent breeds, resulting in a lack of consistency between mtDNA sequences and breeds and/or geographical regions.
Collapse
Affiliation(s)
- C Luís
- Universidade de Lisboa, Faculdade de Ciências, Departamento de Biologia Animal, Centro de Biologia Ambiental, Lisboa, Portugal
| | | | | | | | | |
Collapse
|
17
|
Abstract
The major histocompatibility complex (MHC) genes play well-defined roles in eliciting immune responses and combating infectious diseases. This genetic system is among the most polymorphic. The extent of genetic variation within a population has been directly correlated with fitness for many traits. The MHC class II locus DRA polymorphism was analysed in the endangered Sorraia horse, two other Portuguese and four New World horse breeds considered to be historically close to the Sorraia. Comparison of the Sorraia with other breeds demonstrated less MHC variation among Sorraia horses. If DRA polymorphism provides greater disease resistance, selective breeding to increase MHC polymorphism may increase fitness of this population.
Collapse
Affiliation(s)
- C Luís
- Universidade de Lisboa, Faculdade de Ciências, Departamento de Biologia Animal, Lisboa, Portugal.
| | | | | | | |
Collapse
|
18
|
Affiliation(s)
- C. Luís
- Universidade de Lisboa, Portugal
| | | | - M.M. Oom
- Universidade de Lisboa, Portugal
| |
Collapse
|